George M. Milne Jr. - 24 Jan 2025 Form 4 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Role
Director
Signature
/s/ Joshua B. Cohen, as Attorney in Fact
Issuer symbol
AMLX
Transactions as of
24 Jan 2025
Net transactions value
$0
Form type
4
Filing time
28 Jan 2025, 16:55:45 UTC
Previous filing
05 Sep 2024
Next filing
09 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMLX Common Stock Gift $0 -27,910 -3.3% $0.000000 830,661 24 Jan 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a bona fide gift for no consideration.
F2 These shares of common stock remain subject to a lock-up agreement pursuant to which they cannot be sold prior to March 11, 2025 without the consent of Leerink Partners LLC, subject to certain exceptions.